Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Notes Payables (2023 - 2024)

Lamy (LMMY) has disclosed Notes Payables for 2 consecutive years, with $29000.0 as the latest value for Q3 2024.

  • Quarterly Notes Payables changed 0.0% to $29000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $29000.0 through Aug 2024, changed 0.0% year-over-year, with the annual reading at $29000.0 for FY2024, 0.0% changed from the prior year.
  • Notes Payables hit $29000.0 in Q3 2024 for Lamy, roughly flat from $29000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $29000.0 in Q1 2023 to a low of $29000.0 in Q1 2023.